Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China
· Delayed Price · Currency is CNY 10.46
+0.13 (1.26%)
Mar 10, 2026, 1:45 PM CST
SHA:600267 Revenue
Zhejiang Hisun Pharmaceutical had revenue of 2.67B CNY in the quarter ending September 30, 2025, with 1.57% growth. This brings the company's revenue in the last twelve months to 9.84B, up 3.02% year-over-year. In the year 2024, Zhejiang Hisun Pharmaceutical had annual revenue of 9.79B, down -5.65%.
Revenue (ttm)
9.84B
Revenue Growth
+3.02%
P/S Ratio
1.22
Revenue / Employee
1.23M
Employees
7,994
Market Cap
12.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.79B | -586.22M | -5.65% |
| Dec 31, 2023 | 10.37B | -1.66B | -13.82% |
| Dec 31, 2022 | 12.04B | -99.78M | -0.82% |
| Dec 31, 2021 | 12.14B | 782.07M | 6.89% |
| Dec 31, 2020 | 11.35B | 282.61M | 2.55% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henan Lingrui Pharmaceutical | 3.78B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Guangdong Taienkang Pharmaceutical | 674.49M |
| Porton Pharma Solutions | 3.43B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Zhejiang CONBA Pharmaceutical | 6.58B |